These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 10942939

  • 1. Screening for iron overload and HFE mutations in a university hospital.
    Remacha AF, Carrasco M, Sardà MP, Barceló MJ, Blesa I, Baiget M.
    Haematologica; 2000 Aug; 85(8):873-4. PubMed ID: 10942939
    [No Abstract] [Full Text] [Related]

  • 2. HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
    Remacha AF, Carrasco M, Sardá MP, Barceló MJ, Baiget M.
    Haematologica; 1999 Mar; 84(3):284-5. PubMed ID: 10189401
    [No Abstract] [Full Text] [Related]

  • 3. The S65C mutation in Spain. Implications for iron overload screening.
    Remacha AF, Barceló MJ, Sardà MP, Blesa I, Altés A, Baiget M.
    Haematologica; 2000 Dec; 85(12):1324-5. PubMed ID: 11114141
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology and diagnostic testing for hemochromatosis and iron overload.
    Adams PC.
    Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957
    [Abstract] [Full Text] [Related]

  • 5. The influence of hemochromatosis mutations on iron overload of thalassemia major.
    Longo F, Zecchina G, Sbaiz L, Fischer R, Piga A, Camaschella C.
    Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
    [Abstract] [Full Text] [Related]

  • 6. HFE hemochromatosis: influence of dietary iron intake on the iron overload of C282Y homozygous patients.
    Saliou P, Le Gac G, Mérour MC, Tripogney C, Chanu B, Gourlaouen I, Nousbaum JB, Férec C, Scotet V.
    Ann Hematol; 2015 Jul; 94(7):1225-7. PubMed ID: 25740382
    [No Abstract] [Full Text] [Related]

  • 7. Nontransfusional iron overload in thalassemia. Association with hereditary hemochromatosis.
    Rees DC, Singh BM, Luo LY, Wickramasinghe S, Thein SL.
    Ann N Y Acad Sci; 1998 Jun 30; 850():490-4. PubMed ID: 9668593
    [No Abstract] [Full Text] [Related]

  • 8. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload.
    Townsend A, Drakesmith H.
    Lancet; 2002 Mar 02; 359(9308):786-90. PubMed ID: 11888608
    [Abstract] [Full Text] [Related]

  • 9. Clinical implications of the hemochromatosis gene.
    Tavill AS.
    N Engl J Med; 1999 Sep 02; 341(10):755-7. PubMed ID: 10471465
    [No Abstract] [Full Text] [Related]

  • 10. Screening for hemochromatosis and iron overload: satisfaction with results notification and understanding of mailed results in unaffected participants of the HEIRS study.
    Harrison HF, Harrison BW, Walker AP, Lohman K, Ellis SD, Hall MA, Reiss J, Adams PC, Holup J, Acton RT, Bent T, Rivers C, Fadojutimi-Akinsiku M.
    Genet Test; 2008 Dec 02; 12(4):491-500. PubMed ID: 18939938
    [Abstract] [Full Text] [Related]

  • 11. Clinical consequences of iron overload in hemochromatosis homozygotes.
    Ajioka RS, Kushner JP.
    Blood; 2003 May 01; 101(9):3351-3; discussion 3354-8. PubMed ID: 12707221
    [No Abstract] [Full Text] [Related]

  • 12. Detection of hereditary hemochromatosis and biochemical iron overload in primary care: a multicenter case finding study in Spain.
    Freixenet N, Moreno-Rosel MS, Barceló MJ, Serrano A, Payà M, Crespo L, Pérez-Lucena MJ, Altés A, Baiget M, Félez J.
    Am J Hematol; 2010 Apr 01; 85(4):294-6. PubMed ID: 20196172
    [No Abstract] [Full Text] [Related]

  • 13. Relation between HFE mutations and mild iron-overload expression.
    Mura C, Le Gac G, Raguénes O, Mercier AY, Le Guen A, Férec C.
    Mol Genet Metab; 2000 Apr 01; 69(4):295-301. PubMed ID: 10870847
    [Abstract] [Full Text] [Related]

  • 14. [Clinical usefulness of the detection of mutations of the HFE gene in hemochromatosis].
    Oliva R, Sánchez M, Bruguera M, Rodés J.
    Gastroenterol Hepatol; 2000 Nov 01; 23(9):433-5. PubMed ID: 11126040
    [No Abstract] [Full Text] [Related]

  • 15. Commentary on HFE S65C variant is not associated with increased transferrin saturation in voluntary blood donors by Naveen Arya, Subrata Chakrabrati, Robert A. Hegele, Paul C. Adams.
    Beutler E, Felitti VJ, Ho NJ, Gelbart T.
    Blood Cells Mol Dis; 1999 Nov 01; 25(5-6):358-60. PubMed ID: 10660484
    [No Abstract] [Full Text] [Related]

  • 16. Haemochromatosis: diagnosis and management after the cloning of the HFE gene.
    Powell LW, Bassett ML.
    Aust N Z J Med; 1998 Apr 01; 28(2):159-63. PubMed ID: 9612522
    [No Abstract] [Full Text] [Related]

  • 17. The importance of screening for hemochromatosis.
    Dubois S, Kowdley KV.
    Arch Intern Med; 2003 Nov 10; 163(20):2424-6; author reply 2426. PubMed ID: 14609776
    [No Abstract] [Full Text] [Related]

  • 18. Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation.
    Distante S.
    Scand J Clin Lab Invest; 2006 Nov 10; 66(2):83-100. PubMed ID: 16537242
    [No Abstract] [Full Text] [Related]

  • 19. HFE mutations in an inflammatory arthritis population.
    Willis G, Scott DG, Jennings BA, Smith K, Bukhari M, Wimperis JZ.
    Rheumatology (Oxford); 2002 Feb 10; 41(2):176-9. PubMed ID: 11886966
    [Abstract] [Full Text] [Related]

  • 20. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
    Racchi O, Mangerini R, Rapezzi D, Gaetani GF, Nobile MT, Picciotto A, Ferraris AM.
    Blood Cells Mol Dis; 1999 Feb 10; 25(5-6):350-3. PubMed ID: 10660482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.